The Viscoelastic Haemostatic Assay Landscape in Queensland, Australia: An Analysis of Use, Indications and Integration
Emergency Medicine Australasia · 2025
DOI: 10.1111/1742-6723.70131 ↗Kurz gefasst
Fachartikel in der Zeitschrift Emergency Medicine Australasia, 2025. Verfasst von Akmez Latona und 4 weiteren Autor:innen. Beteiligte Einrichtung: Emergency Department, Ipswich Hospital, Ipswich, Queensland, Australia. Hauptthemen laut MEDLINE: Thrombelastography, Hemorrhage. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Emergency Medicine Foundation.
Abstract (Originalsprache)
Background
Viscoelastic haemostatic assays ( VHAs ) guide transfusion decisions in bleeding patients. We assessed testing volumes, clinical indications and patient characteristics in a statewide population in Australia.
Methods
This retrospective study included all patients who underwent rotational thromboelastometry ( ROTEM ) or thromboelastography ( TEG ) across Queensland Health hospitals (1 January 2019 to 15 April 2025), using data from AUSLAB , the statewide laboratory information system and surveyed all hospitals for VHA device availability.
Result
Of 39 VHA devices, 31 were transmitting to AUSLAB , with 43,220 tests performed in 21,178 patients, during 18,389 admissions and 6418 ED presentations; 92.0% were ROTEM ( n = 39,776) and 8.0% TEG ( n = 3444). Most tests occurred during inpatient care ( n = 35,527, 82.2%) versus ED ( n = 7693, 17.8%). Indications included trauma ( n = 23,875, 55.2%), non‐variceal gastrointestinal bleeding ( n = 4238, 9.8%), obstetrics ( n = 3307, 7.7%) and chronic liver disease ( CLD ) ( n = 3853, 8.9%), including 1097 (2.5%) with variceal bleeding. Emergency department (ED) use increased overall (IRR 1.14; 95% CI 1.12–1.15), including trauma (IRR 1.15), CLD (1.16), variceal bleeding (1.12) and non‐variceal bleeding (1.12) (all p < 0.001); obstetric use in ED did not change significantly (IRR 0.93; 95% CI 0.86–1.00). Inpatient use also increased (IRR 1.21; 95% CI 1.21–1.22), including trauma (IRR 1.22), CLD (1.16), variceal (1.10), non‐variceal bleeding (1.17) and obstetrics (1.07) (all p < 0.001).
Conclusion
VHA use increased in both ED and inpatient settings, with prominent use in trauma and CLD . The results indicate growing recognition by clinicians of VHA 's value in guiding haemorrhage management. The need for a consistent, evidence‐based approach to testing and interpretation of results is paramount.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Emergency Department, Ipswich Hospital, Ipswich, Queensland, Australia.
- LifeFlight Retrieval Medicine, Toowoomba, Queensland, Australia.
- School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
- The University of Queensland Faculty of Medicine, Brisbane, Queensland, Australia.
- Central Laboratory, Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
- Intensive Care Unit, Gold Coast University Hospital, Gold Coast, Queensland, Australia.
ORCID-Profile: Akmez Latona, Biswadev Mitra
Förderung
- Emergency Medicine Foundation
Zitieren
APA
Latona, A., Lennard, S., Rane, M., Winearls, J., & Mitra, B. (2025). The Viscoelastic Haemostatic Assay Landscape in Queensland, Australia: An Analysis of Use, Indications and Integration. Emergency Medicine Australasia. https://doi.org/10.1111/1742-6723.70131
Vancouver
Latona A, Lennard S, Rane M, Winearls J, Mitra B. The Viscoelastic Haemostatic Assay Landscape in Queensland, Australia: An Analysis of Use, Indications and Integration. Emergency Medicine Australasia. 2025. doi:10.1111/1742-6723.70131
BibTeX
@article{Latona2025,
author = {Latona, Akmez and Lennard, Samantha and Rane, Mark and Winearls, James and Mitra, Biswadev},
title = {The Viscoelastic Haemostatic Assay Landscape in Queensland, Australia: An Analysis of Use, Indications and Integration},
journal = {Emergency Medicine Australasia},
year = {2025},
doi = {10.1111/1742-6723.70131}
}
EUVIMED